CORONA Remedies Limited has informed the Exchange about change in ManagementRe-appointment of M/s. Manish B. Analkat, as Cost Auditor of the Company for the Financial Year 2026-27
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
CORONA Remedies Limited has re-appointed M/s. Manish B. Analkat as Cost Auditor for the financial year 2026-27. Cost auditors are appointed to examine and verify the company's cost accounting records as mandated under the Companies Act. This is a routine annual re-appointment, indicating continuity in the company's compliance framework. The filing falls under the 'Change in Management' category on NSE due to auditor appointments being classified under management changes.
This is a routine governance action with no material impact on shareholders or stock price. The re-appointment of an existing cost auditor suggests smooth ongoing operations and compliance.